Solid Organ Transplant Recipients with Pretransplant Cancer Have an Elevated Risk of Posttransplant Cancer of the Same Cancer Type By Ogkologos - March 30, 2026 78 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the Transplant Cancer Match Study Source RELATED ARTICLESMORE FROM AUTHOR Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for Localised TNBC ESMO Advocates for Equal Access to Optimal Cancer Care for all Patients with Cancer at the 79th World Health Assembly Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic Ductal Adenocarcinoma MOST POPULAR A toolkit to address disparities in digitally enabled oncology trials September 5, 2025 Workout Wednesdays – Leg Exercises Part 3 June 24, 2020 Mother Spent 14 Weeks Battling Breast Cancer Alone During COVID-19 Lockdown October 20, 2020 Outcomes From Second-Line Chemotherapy in Patients with Cholangiocarcinoma and FGFR2 Fusions July 1, 2020 Load more HOT NEWS Savolitinib Plus Osimertinib Show a High Response in EGFR-mutated NSCLC Progressed... Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell... Copanlisib Shows Promising Clinical Activity in Select Tumours with PIK3CA Mutation... Sotorasib Shows Promising Activity and Acceptable Safety in Patients with Previously...
